| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.54 | 4e-26 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-15 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.33 | 6e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0007 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.45 | 0.002 |